Founded in 2001, Lab901 employs around 45 people. With the addition of Lab901’s excellent technology and talented team, Agilent can now address customer needs across the entire period of electrophoresis life technology applications – from semi-automated to 96-well-plate suitable workflows, said Patrick Kaltenbach, vice president of Agilent’s Liquid Phase Separations business. Alongside our existing BioAnalyzer platform and the Agilent G7100 Electrophoresis Program, the Laboratory901 ScreenTape system offers a very versatile, scalable and automatic throughput gel electrophoresis solution for a wide range of applications.‘To date, most taxations and bans like the New York proposal are based on theoretical models. There is conflicting study on whether these programs actually bring about behavior change leading to positive health outcomes.’ Related StoriesHi-Tech Pharmaceuticals indicators definitive agreement to obtain iForceClinical dietitian provides ideas to reduce red meats consumptionGLP-2 therapy can help fight neonatal parenteral nutrition-linked liver diseaseEscott-Stump added: ‘As a science-based organization, the Academy of Nutrition and Dietetics believes there should be an evaluation element of these programs. We have to measure behavior changes across the population due to the program. Then, we can determine if the adjustments are long-term and whether they contribute to a reduction of chronic illnesses like obesity and diabetes.’ The Academy has convened a working group to examine the potency of measures like proposed bans and taxes that can influence consumers’ purchases and their potential effect on people’s health.